Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)
Clinical trial NCT05712902 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05712902
- Sponsor
- Dizal Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2022-10-17
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.